Company Profile

Abilita Bio Inc
Profile last edited on: 3/24/23      CAGE: 77UL8      UEI: DEYUQFS2MLT5

Business Identifier: Membrane protein-targeted therapeutics
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6888 Nancy Ridge Drive
San Diego, CA 92117
   (858) 366-5435
Location: Single
Congr. District: 52
County: San Diego

Public Profile

A well-established firm closing in on a decade in business and recently (2023) in receipt of substantial VC funding, Abilita Bio is a biotechnology company - an alumni of JLabs San Diego - addressing enabling discovery and development of drugs targeting challenging membrane proteins, including G Protein-Coupled Receptors (GPCRs) and ion channels, including G Protein Coupled Receptors (GPCRs) and ion channels. A privately held, innovation-driven biotechnology company focused on discovering and developing therapeutic antibodies targeting the most challenging and medically important multi-span membrane proteins. Abilita Bio’s validated drug discovery engine builds on the foundation of its powerful EMP™ target evolution platform and deep membrane protein expertise to a suite of internal antibody discovery technologies.The firm has established research collaborations with global pharmaceutical companies to advance their internal drug discovery programs targeting GPCRs and ion channels and continues to extend the EMP™ platform into new applications through multiple risk-sharing collaborations with biotechnology industry partners, while leveraging the EMP™ platform to fuel a robust internal drug discovery pipeline focused on treating cancer and chronic

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Mauro Mileni -- Founder President and CEO

  Alexander Alexandrov -- Princpal Scientist

  Rosario B Billetta

  Christopher B Bolt -- VP Innovation

  Louis J Cantolupo -- Business Development

  Lynda Groocock

  Heather Pascual

  Dario Ranieri -- Research Associate

  Chris Roth -- Vice President

Company News

There are no news available.